Alnylam Pharmaceuticals

Alnylam is the leading RNAi therapeutics company. We are a U.S.-based biopharmaceutical company with operations around the world. Founded in 2002 on a bold vision to turn Nobel Prize-winning science into an entirely new class of medicines, Alnylam has worked tirelessly for over 16 years to turn the scientific possibility of RNAi into a therapeutic reality. We believe that our efforts have the potential to improve the lives of patients worldwide who are waiting for new treatment options.